Summary
Cardinal Health Inc. (CAH) filed an 8-K report on May 15, 2012, to disclose information regarding actions taken by the Drug Enforcement Administration (DEA) at the company's distribution center located in Lakeland, Florida. This report's primary purpose is to provide transparency to investors about a significant regulatory event that could potentially impact operations or reputation. The press release, attached as Exhibit 99.1, details the nature of the DEA's actions. While the 8-K itself does not elaborate on the specifics of the DEA's investigation or its potential ramifications, it signals a material event that investors should be aware of. The company is utilizing Regulation FD disclosure to ensure all market participants receive this information concurrently.
Key Highlights
- 1Cardinal Health is disclosing actions taken by the Drug Enforcement Administration (DEA) at its Lakeland, Florida distribution center.
- 2The company filed a Form 8-K on May 15, 2012, to report this event.
- 3The disclosure is made under Regulation FD to ensure fair and simultaneous information dissemination to all investors.
- 4A press release detailing the DEA's actions is attached as Exhibit 99.1 to the 8-K filing.
- 5The 8-K does not provide extensive details on the nature or impact of the DEA's actions, directing readers to the press release for more information.
- 6This event represents a material development requiring disclosure to the investing public.